WSFS names Chuck Mosher chief audit executive
Bitget2026/10/06 13:04WSFS named Charles “Chuck” Mosher executive vice president, chief audit executive, following his stint as interim chief auditor. Mosher joined over 25 years ago; previously served as senior vice president, chief accounting officer overseeing accounting, financial reporting, controls. Michael “Mike” Thompson appointed senior vice president, interim chief accounting officer; previously CFO and COO of Bryn Mawr Trust’s banking division. Thompson has nearly 30 years’ banking experience; earlier served as CFO and chief accounting officer at Royal Bancshares of Pennsylvania. Lisa Washington promoted to executive vice president, chief legal officer, corporate secretary; previously senior vice president, chief legal officer since 2019. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WSFS Financial Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005040209) on October 06, 2026, and is solely responsible for the information contained therein.
- WSFS named Charles “Chuck” Mosher executive vice president, chief audit executive, following his stint as interim chief auditor.
- Mosher joined over 25 years ago; previously served as senior vice president, chief accounting officer overseeing accounting, financial reporting, controls.
- Michael “Mike” Thompson appointed senior vice president, interim chief accounting officer; previously CFO and COO of Bryn Mawr Trust’s banking division.
- Thompson has nearly 30 years’ banking experience; earlier served as CFO and chief accounting officer at Royal Bancshares of Pennsylvania.
- Lisa Washington promoted to executive vice president, chief legal officer, corporate secretary; previously senior vice president, chief legal officer since 2019.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Chip design software leader Synopsys seeks collaboration with Chinese large model laboratories
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
Crypto prices
More
